TY - JOUR
T1 - The Long Path of Human Placenta, and Its Derivatives, in Regenerative Medicine
AU - Silini, Antonietta R.
AU - Cargnoni, Anna
AU - Magatti, Marta
AU - Pianta, Stefano
AU - Parolini, Ornella
PY - 2015
Y1 - 2015
N2 - In the 1800s, a baby born with a caul, a remnant of the amniotic sack or fetal membranes, was thought to be lucky, special, or protected. Over time, fetal membranes lost their legendary power and were soon considered nothing more than biological waste after birth. However, placenta tissues have reclaimed their potential and since the early 1900s an increasing body of evidence has shown that these tissues have clinical benefits in a wide range of wound repair and surgical applications. Nowadays, there is a concerted effort to understand the mechanisms underlying the beneficial effects of placental tissues, and, more recently, cells derived thereof. This review will summarize the historical and current clinical applications of human placental tissues, and cells isolated from these tissues, and discuss some mechanisms thought to be responsible for the therapeutic effects observed after tissue and/or cell transplantation
AB - In the 1800s, a baby born with a caul, a remnant of the amniotic sack or fetal membranes, was thought to be lucky, special, or protected. Over time, fetal membranes lost their legendary power and were soon considered nothing more than biological waste after birth. However, placenta tissues have reclaimed their potential and since the early 1900s an increasing body of evidence has shown that these tissues have clinical benefits in a wide range of wound repair and surgical applications. Nowadays, there is a concerted effort to understand the mechanisms underlying the beneficial effects of placental tissues, and, more recently, cells derived thereof. This review will summarize the historical and current clinical applications of human placental tissues, and cells isolated from these tissues, and discuss some mechanisms thought to be responsible for the therapeutic effects observed after tissue and/or cell transplantation
KW - amniotic and chorionic membranes
KW - clinical trials
KW - human term placenta
KW - immunomodulation
KW - paracrine effect
KW - regenerative medicine
KW - stem cells
KW - umbilical cord
KW - amniotic and chorionic membranes
KW - clinical trials
KW - human term placenta
KW - immunomodulation
KW - paracrine effect
KW - regenerative medicine
KW - stem cells
KW - umbilical cord
UR - http://hdl.handle.net/10807/92252
U2 - 10.3389/fbioe.2015.00162
DO - 10.3389/fbioe.2015.00162
M3 - Article
SN - 2296-4185
VL - 3
SP - 162
EP - 177
JO - Frontiers in Bioengineering and Biotechnology
JF - Frontiers in Bioengineering and Biotechnology
ER -